1. Home
  2. ZNB vs CDT Comparison

ZNB vs CDT Comparison

Compare ZNB & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zeta Network Group Class A Ordinary Shares

ZNB

Zeta Network Group Class A Ordinary Shares

N/A

Current Price

$0.62

Market Cap

1.8M

ML Signal

N/A

Logo Conduit Pharmaceuticals Inc.

CDT

Conduit Pharmaceuticals Inc.

HOLD

Current Price

$1.35

Market Cap

2.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZNB
CDT
Founded
N/A
2019
Country
United States
United States
Employees
47
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8M
2.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ZNB
CDT
Price
$0.62
$1.35
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
163.5K
Earning Date
N/A
03-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
$1.26
52 Week High
N/A
$2,198.40

Technical Indicators

Market Signals
Indicator
ZNB
CDT
Relative Strength Index (RSI) 41.60 39.03
Support Level $0.56 $1.61
Resistance Level $0.66 $1.75
Average True Range (ATR) 0.08 0.11
MACD 0.01 -0.02
Stochastic Oscillator 11.64 26.15

Price Performance

Historical Comparison
ZNB
CDT

About ZNB Zeta Network Group Class A Ordinary Shares

Zeta Network Group is an entertainment technology company with a network that focuses on the application of technology and artificial intelligence in the entertainment industry. It provides online entertainment performances and online education through its wholly-owned subsidiaries Color Metaverse and CACM. The curriculum developed by the company includes music, sports, animation, painting and calligraphy, film and television, and life skills, covering various aspects of entertainment, sports, and culture.

About CDT Conduit Pharmaceuticals Inc.

CDT Equity Inc, formerly Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Share on Social Networks: